BriaCell Therapeutics Corp., a publicly-traded Canadian company, and Ceptur Therapeutics Inc., a New Jersey company developing gene-based medicines, are among those tenants leasing space at Brandywine Realty Trust’s B. Labs incubator at Cira Centre. Half of the 50,000-square-foot incubator has been leased, according to the real estate company. Other tenants include: Leal Therapeutics, which is… Read more »
Real estate companies that focus on developing lab and manufacturing space for life sciences companies are circling 3900 Market St., the site of University City Townhomes, an affordable housing complex that was put up for sale. A bidding process for the property, the size of a city block, is being overseen by a commercial real… Read more »
An aging monument of Philadelphia’s industrial past is poised to become a harbinger of the city’s future as a life sciences hub. After 18 years of lying dormant, the Budd Co. Hunting Park plant, which at its prime employed some 7,000 workers who made parts for automobiles and trains, is undergoing a transformation into a… Read more »
Brandywine Realty Trust plans to develop a site at its Metroplex Corporate Center off Chemical Road in Plymouth Meeting for life sciences research and manufacturing space. The Philadelphia real estate investment trust is seeking approvals for a single-story, 100,000-square-foot building that would be used for manufacturing and another 125,000-square-foot building that would be designed for… Read more »
Iron Stone Real Estate Partners, which recently acquired part of the former Hahnemann University Hospital complex, plans to offer one of the buildings as research and development laboratories for the Philadelphia region’s growing life sciences sector. The Hahnemann structure Iron Stone selected for labs had housed Hahnemann’s in-house labs. That gives it an advantage over… Read more »
The owner of the sprawling former Budd Co. property in Philadelphia plans to transform it into a biomanufacturing hub, seizing upon Philadelphia’s burgeoning life sciences sector and demand by companies that need the space. Backed by Centerbridge Partners, a New York private equity firm, Plymouth Group envisions a multi-phased, multiyear development of the site that… Read more »
During the throes of the pandemic in the spring of 2020 and in the middle of constructing its new $1.5 billion hospital, Penn Medicine switched gears to focus on creating extra capacity at the building for a potential influx of Covid-19 patients. A little more than a year later, Penn Medicine’s Pavilion is in its… Read more »
